Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery

NCT00101036 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

57

Enrollment

NIH

Sponsor class

Conditions

Adult Primary Hepatocellular Carcinoma
Advanced Adult Primary Liver Cancer
Localized Unresectable Adult Primary Liver Cancer
Recurrent Adult Primary Liver Cancer
Recurrent Extrahepatic Bile Duct Cancer
Recurrent Gallbladder Cancer
Unresectable Extrahepatic Bile Duct Cancer
Unresectable Gallbladder Cancer

Interventions

DRUG: lapatinib ditosylate
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)